Stephen Johnson
Managing Editor, Big Think
Stephen Johnson is the Managing Editor of Big Think. Formerly a long-time contributor to Big Think, he is a St. Louis-based writer and editor whose work has been featured in U.S. News & World Report, PBS Digital Studios, Eleven Magazine, and The Missourian.
The move comes amid a surge of vaping-related hospitalizations.
An A.I. named Aristo was able to use its language and logic skills to pass a standardized exam with flying colors.
But some say the settlement is a slap on the wrist.
The Category 5 hurricane was moving at speeds of about 1 mph over the Bahamas on Sunday and Monday.
The effects of deforestation extend farther than previously thought.
Experts are saying it’s a “huge step forward for synthetic biology.”
The water tower-shaped craft is an early prototype of Starship, which SpaceX hopes will someday send humans to Mars.
Ecosia says the funds generated from users’ searches help to plant one tree every second.
What’s next for the nation’s opioid cases?
How many other disease-fighting compounds might we find in the ocean?
Can the duo make plant-based chicken taste “finger lickin’ good”?
The world’s largest retailer has evolved “like a flea market,” according to a new report from The Wall Street Journal.
Emojis might contain more emotional information than meets the eye.
The Amazon Rainforest is often called “The Planet’s Lungs.”
The 2020 Democratic candidate’s plan to give Americans a universal basic income seems to include a special provision for truckers.
In a new study, people who posted a lot of selfies were generally viewed as less likeable and more lonely.
E-cigarettes might possibly be safer than traditional cigarettes, but they come with their own risks.
In modern disinformation warfare, social media is the main battlefield.
A new study estimated the untapped potential of wind energy across Europe.
A group representing more than 100 of the biggest corporations in the U.S. has released a statement updating its definition of the purpose of American corporations.
The results could have important implications for the business world.
TuSimple, an autonomous trucking company, has also engaged in test programs with the United States Postal Service and Amazon.
A recent clinical trial shows that two new drugs are far more effective than current treatments.
Scientists continue to learn more about this class of plant chemicals that’s known to have extraordinary health benefits.
The startling discovery comes from researchers with the U.S. Geological Survey.
Some nations can’t afford to make climate change a political issue.
The synthetic chemicals — called PFAS — never break down naturally.
The writing is on the wall for the oil industry, according to a new report from BNP Paribas.
It’s not about what guns people have. It’s who has them.
Do scientists know enough about gene editing to move forward with human trials?